Matches in Nanopublications for { ?s ?p "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP678976.RAU2-tDVMUnfVB3YVxB7pKDjftoEoOTE59cXYhPMgNgM4130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678976.RAU2-tDVMUnfVB3YVxB7pKDjftoEoOTE59cXYhPMgNgM4130_provenance.
- assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP679136.RACY_awsbeNDi8hf-xJcWC4N5wDKSGmHg4hDxMV6RtyGo130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679136.RACY_awsbeNDi8hf-xJcWC4N5wDKSGmHg4hDxMV6RtyGo130_provenance.
- NP679347.RAr10K97yK42f12E2C0AmoF4mDG3QoHfgDI9guDJ2T1kc130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679347.RAr10K97yK42f12E2C0AmoF4mDG3QoHfgDI9guDJ2T1kc130_provenance.
- NP1151479.RAu2C77YmOFjiGHrLnbWLwPjdXbOgzfSfYBAy6mEojFqo130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1151479.RAu2C77YmOFjiGHrLnbWLwPjdXbOgzfSfYBAy6mEojFqo130_provenance.
- NP1151480.RAr3f691jNX2iU2SKBKpqDDX_0oXIele5Kxp2ECaHJdy4130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1151480.RAr3f691jNX2iU2SKBKpqDDX_0oXIele5Kxp2ECaHJdy4130_provenance.
- NP678644.RA7qBMeco4McuCaD-pQk1NEilj3FxBNkHzVNAaHUXTgbM130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678644.RA7qBMeco4McuCaD-pQk1NEilj3FxBNkHzVNAaHUXTgbM130_provenance.
- NP1151477.RA9wcO45633KHNWDmRLhxoKIlxupzbO-S9JifB78bL9LI130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1151477.RA9wcO45633KHNWDmRLhxoKIlxupzbO-S9JifB78bL9LI130_provenance.
- NP1151478.RA9fd7c7ALEuNukhWQvvRtnoto2BIhY48OZ3HjfdSjGsc130_assertion description "[These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1151478.RA9fd7c7ALEuNukhWQvvRtnoto2BIhY48OZ3HjfdSjGsc130_provenance.